IBUB researchers design a drug capable of acting simultaneously against three different therapeutic targets

Study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different therapeutic target within the cell. The paper, published in the journal Bioorganic Chemistry, presents a proof-of-concept of this innovative triple-targeting compound, which

IBUB scientists consolidate their position in the top 2% of scientists with the highest impact worldwide.

Recently Stanford University has again updated the databases of authors across all of science updated with standardized citation indicators. They have created a publicly available database of top-cited scientists that provides standardized information on citations, h-index, co-authorship adjusted hm-index, citations to papers in different authorship positions and a composite indicator (c-score). Separate data are shown

Decipher new molecular mechanisms related to biological tissue regeneration

A study published in The EMBO Journal opens new perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumour necrosis factor-α (TNF-α) and its receptors TNFR, molecules of key interest in biomedicine due to their involvement in multiple diseases such as obesity related to type 2 diabetes

Researchers identify sex differences in genetic vulnerability to psychotic disorders

A team of researchers from the IBUB, University of Barcelona and the Centre for Biomedical Research in the Mental Health Network (CIBERSAM) has published a pioneering study that reveals significant findings in the field of genetic psychiatry from the perspective of separate gender analysis. Firstly, the paper confirms the existence of a shared genetic vulnerability between schizophrenia and

Emerging Leaders in Biomedicine

An event specifically tailored for advanced postdoctoral researchers and junior Group Leaders who are at the forefront of the vibrant biomedical community of the Barcelona area. The Emerging Leaders in Biomedicine symposium is now a key meeting point for the next generation of CancerResearch leaders. It aims to build a network of new group leaders

46º Congreso de la Sociedad Española de Bioquímica y Biología Molecular

The Sociedad Española de Bioquímica y Biología Molecular (SEBBM) celebrates the 46th congress, September 3-6, 2024, in A Coruña. As every year, the IBUB awards € 2,500 to the young researcher in recognition of the research career in the area of Biochemistry and Molecular Biology. This year the IBUB researcher and coordinator of the Metabolism

14th Summer School on Medicines

This year marks the 14th edition of the Summer School of Medicines (SSM14), for the second time at the School of Medicine of Ribeirão Preto, at the University of São Paulo Campus. In this edition, students will be immersed in very in-depth content, participating in interactive lectures, case studies and the opportunity to network with

Cybersecurity Day in Research

Date: July 1, 2024 from 9:30 a.m. to 12:00 a.m.Place: Aula capella, historical UB building. 9:30 h InaugurationDr. Joan Guàrdia (Rector).Dr. Jordi García (Vice-Rector for Research).Dr. Xavier Triadó (Vice-Rector for Digitalization Policy). 10:00 h “Big picture” of cybersecurity today.Mr. Carlos Garrido and Sergi Baouso security area of the Cos de Mossos d’Esquadra. 10:30 h Radiografia

New therapeutic targets to fight type 2 diabetes

One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels. This is because in these insulin-resistant patients, glucose production by the liver is triggered, a process that is still full of questions for the scientific community. Now, a review article published in the journal